Exchanges
BSE, NSE
Industry
Pharmaceuticals
Issue
Book building

Senores Pharmaceuticals IPO

₹557.80

+42.66% on listing

Listing-day close · BSE · 30 Dec 2024 · issue price ₹391

Senores Pharmaceuticals’ ₹582 crore IPO was priced at ₹391 a share. It listed on the BSE on 30 Dec 2024 and closed its first day at ₹557.80, up 42.66% on the issue price.

Timeline

  1. Opens
  2. Closes
  3. Allotment
  4. Refunds
  5. Shares in demat
  6. Listing

Issue details

Issue size
₹582 Cr
Fresh issue
₹500 Cr
Offer for sale
₹82.11 Cr
Lot size
38 shares
Minimum investment
₹14,858
Face value
₹10
Registrar
MUFG Intime India

Subscription

Senores Pharmaceuticals IPO subscription by investor category
CategoryShares offeredTimes subscribed
Total—54.02×

Overall, from the basis of allotment.

Financials and valuation

Market cap (post-issue)
₹1,351 Cr
P/E (post-issue)
28.2
EPS (post-issue)
₹13.86
Price to book
5.8
ROE
23.60%
ROCE
11.73%
Debt to equity
1.07
PAT margin
15.25%
Promoter holding
66.67% → 45.77%

Financials as of 31 Mar 2024, from the offer documents.

Listing

Listing date
30 Dec 2024
Issue price
₹391
Open
₹593.70
High
₹609.00
Low
₹538.85
Close
₹557.80

Listing day on the BSE. The close was +42.66% on the issue price.

SENORES PHARMACEUTICALS L share price today

FAQs

When did the Senores Pharmaceuticals IPO open and close?

It opened on 20 Dec 2024 and closed on 24 Dec 2024.

What was the Senores Pharmaceuticals IPO price?

The price band was ₹372–391 a share. The final issue price was ₹391.

What is the lot size and minimum investment?

One lot is 38 shares, ₹14,858 at ₹391 a share. Retail investors apply in whole lots.

How much did Senores Pharmaceuticals raise?

₹582 crore: ₹500 crore of new shares and ₹82.11 crore offered by existing shareholders.

How many times was the Senores Pharmaceuticals IPO subscribed?

54.02 times overall.

How did Senores Pharmaceuticals list?

It listed on the BSE on 30 Dec 2024 at ₹593.70 and closed the day at ₹557.80, up 42.66% on the ₹391 issue price.

Who is the registrar of the Senores Pharmaceuticals IPO?

MUFG Intime India handles the allotment, refunds and credit of shares.

For information only. Not investment advice or a research report.

Full disclaimer

See how an IPO fits your plan

Armor checks every holding against your goals, risk and timeline.

Get the app